Clinical Trial

Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure

Study acronym: VETtiPAT-ARF
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 17, 2024 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Patients with coronavirus disease (COVID) and non-COVID acute respiratory failure (ARF) may be at an increased risk of thrombosis due to increased clot formation and decreased clot lysis. This two stage study aims to utilise bedside coagulation technology to detect patients at increased risk and guide tPA treatment to maximise efficacy and safety through a personalised approach.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-09-12; most recent amendment 2024-04-15.
Trial Details
NCT Number NCT05540834
Lead Sponsor South West Sydney Local Health District
Conditions Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown
Enrollment 70 participants
Start Date 2022-05-18
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-04-17